Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Agensys, Inc.

Home Clinical Trial Sponsors and OrganizationsAgensys, Inc.

Agensys, Inc.

ACTIVE

加利福尼亚州洛杉矶县, California, United Stateswww.agensys.comSubsidiary251–500 employeesEstablished: 1997-01-01

Part of ASTELLAS PHARMA US, INC.

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

3

1 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

1997

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

1

33.3%

Phase 2

1

33.3%

Trial Status Distribution

Active, not recruiting

1

33.3%

Completed

2

66.7%

Clinical Trials

Trials sponsored by this organization (3)

A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002

Aug 20122 participants

A Study to Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear Cell or Papillary Histology

Jul 201234 participants

A Global, Multi-center, Open-label, Phase 2 Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects with Metastatic Pancreatic Cancer?Estudio global, multicéntrico, abierto, de fase II de AGS-1C4D4 administrado en combinación con gemcitabina en sujetos con cáncer de páncreas metastásico.

Active, not recruiting

Feb 2010185 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials3
Approvals
News

Back to Organizations